Peterson Kristine 4
4 · ArriVent BioPharma, Inc. · Filed Jun 20, 2025
Insider Transaction Report
Form 4
Peterson Kristine
Director
Transactions
- Award
Non-Qualified Stock Option (right to buy)
2025-06-18+15,502→ 15,502 totalExercise: $24.89From: 2026-06-18Exp: 2035-06-17→ Common Stock (15,502 underlying)